vs
太平洋生物科学（ASMB）与FIRST US BANCSHARES, INC.（FUSB）财务数据对比。点击上方公司名可切换其他公司
太平洋生物科学的季度营收约是FIRST US BANCSHARES, INC.的1.0倍（$10.8M vs $10.4M），FIRST US BANCSHARES, INC.净利率更高（20.4% vs -85.2%，领先105.7%），太平洋生物科学同比增速更快（57.6% vs 7.1%），FIRST US BANCSHARES, INC.自由现金流更多（$9.1M vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
第一美国银行控股公司是一家银行控股企业，核心子公司第一公民银行在美国23个州经营着超过500家网点，另一家子公司硅谷银行则在15个州设有39个办事处，是美国规模较大的银行机构之一，总部位于北卡罗来纳州罗利。
ASMB vs FUSB — 直观对比
营收规模更大
ASMB
是对方的1.0倍
$10.4M
营收增速更快
ASMB
高出50.5%
7.1%
净利率更高
FUSB
高出105.7%
-85.2%
自由现金流更多
FUSB
多$24.3M
$-15.2M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $10.4M |
| 净利润 | $-9.2M | $2.1M |
| 毛利率 | — | — |
| 营业利润率 | -100.9% | 28.1% |
| 净利率 | -85.2% | 20.4% |
| 营收同比 | 57.6% | 7.1% |
| 净利润同比 | 4.3% | 24.2% |
| 每股收益（稀释后） | $-0.72 | $0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBFUSB
| Q4 25 | — | $10.4M | ||
| Q3 25 | $10.8M | $10.5M | ||
| Q2 25 | $9.6M | $10.3M | ||
| Q1 25 | $9.4M | $9.8M | ||
| Q4 24 | $7.4M | $9.7M | ||
| Q3 24 | $6.8M | $10.1M | ||
| Q2 24 | $8.5M | $10.0M | ||
| Q1 24 | $5.8M | $9.9M |
净利润ASMBFUSB
| Q4 25 | — | $2.1M | ||
| Q3 25 | $-9.2M | $1.9M | ||
| Q2 25 | $-10.2M | $155.0K | ||
| Q1 25 | $-8.8M | $1.8M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | $-9.6M | $2.2M | ||
| Q2 24 | $-11.2M | $2.1M | ||
| Q1 24 | $-9.1M | $2.1M |
营业利润率ASMBFUSB
| Q4 25 | — | 28.1% | ||
| Q3 25 | -100.9% | 23.9% | ||
| Q2 25 | -115.2% | 1.6% | ||
| Q1 25 | -105.5% | 23.8% | ||
| Q4 24 | — | 23.8% | ||
| Q3 24 | -160.1% | 29.2% | ||
| Q2 24 | -143.0% | 27.4% | ||
| Q1 24 | -185.5% | 27.8% |
净利率ASMBFUSB
| Q4 25 | — | 20.4% | ||
| Q3 25 | -85.2% | 18.4% | ||
| Q2 25 | -105.9% | 1.5% | ||
| Q1 25 | -93.6% | 18.1% | ||
| Q4 24 | — | 17.6% | ||
| Q3 24 | -140.4% | 22.0% | ||
| Q2 24 | -130.7% | 21.2% | ||
| Q1 24 | -156.9% | 21.3% |
每股收益（稀释后）ASMBFUSB
| Q4 25 | — | $0.36 | ||
| Q3 25 | $-0.72 | $0.32 | ||
| Q2 25 | $-1.33 | $0.03 | ||
| Q1 25 | $-1.17 | $0.29 | ||
| Q4 24 | — | $0.29 | ||
| Q3 24 | $-1.51 | $0.36 | ||
| Q2 24 | $-1.98 | $0.34 | ||
| Q1 24 | $-1.66 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $73.5M |
| 总债务越低越好 | — | $10.9M |
| 股东权益账面价值 | $182.7M | $105.6M |
| 总资产 | $240.0M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.10× |
8季度趋势，按日历期对齐
现金及短期投资ASMBFUSB
| Q4 25 | — | $73.5M | ||
| Q3 25 | $22.5M | $54.7M | ||
| Q2 25 | $24.0M | $54.0M | ||
| Q1 25 | $23.4M | $56.0M | ||
| Q4 24 | $38.3M | $47.2M | ||
| Q3 24 | $28.5M | $82.3M | ||
| Q2 24 | $19.2M | $58.2M | ||
| Q1 24 | $18.7M | $60.2M |
总债务ASMBFUSB
| Q4 25 | — | $10.9M | ||
| Q3 25 | — | $10.9M | ||
| Q2 25 | — | $10.9M | ||
| Q1 25 | — | $10.9M | ||
| Q4 24 | — | $10.9M | ||
| Q3 24 | — | $10.9M | ||
| Q2 24 | — | $10.8M | ||
| Q1 24 | — | $10.8M |
股东权益ASMBFUSB
| Q4 25 | — | $105.6M | ||
| Q3 25 | $182.7M | $104.2M | ||
| Q2 25 | $18.1M | $101.9M | ||
| Q1 25 | $27.1M | $101.2M | ||
| Q4 24 | $33.4M | $98.6M | ||
| Q3 24 | $26.0M | $98.5M | ||
| Q2 24 | $34.7M | $93.8M | ||
| Q1 24 | $32.6M | $92.3M |
总资产ASMBFUSB
| Q4 25 | — | $1.2B | ||
| Q3 25 | $240.0M | $1.1B | ||
| Q2 25 | $80.8M | $1.1B | ||
| Q1 25 | $99.0M | $1.1B | ||
| Q4 24 | $119.2M | $1.1B | ||
| Q3 24 | $100.3M | $1.1B | ||
| Q2 24 | $115.3M | $1.1B | ||
| Q1 24 | $119.9M | $1.1B |
负债/权益比ASMBFUSB
| Q4 25 | — | 0.10× | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $12.3M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $9.1M |
| 自由现金流率自由现金流/营收 | -140.7% | 87.2% |
| 资本支出强度资本支出/营收 | 0.4% | 31.1% |
| 现金转化率经营现金流/净利润 | — | 5.79× |
| 过去12个月自由现金流最近4个季度 | — | $16.0M |
8季度趋势，按日历期对齐
经营现金流ASMBFUSB
| Q4 25 | — | $12.3M | ||
| Q3 25 | $-15.1M | $4.2M | ||
| Q2 25 | $-16.8M | $3.9M | ||
| Q1 25 | $-23.4M | $1.8M | ||
| Q4 24 | $-51.1M | $7.8M | ||
| Q3 24 | $-15.2M | $1.9M | ||
| Q2 24 | $-17.1M | $2.5M | ||
| Q1 24 | $-18.4M | $825.0K |
自由现金流ASMBFUSB
| Q4 25 | — | $9.1M | ||
| Q3 25 | $-15.2M | $3.6M | ||
| Q2 25 | — | $1.6M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | $-51.1M | $5.7M | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | $-17.1M | $2.3M | ||
| Q1 24 | $-18.4M | $-142.0K |
自由现金流率ASMBFUSB
| Q4 25 | — | 87.2% | ||
| Q3 25 | -140.7% | 34.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 17.2% | ||
| Q4 24 | -695.2% | 58.2% | ||
| Q3 24 | — | 12.7% | ||
| Q2 24 | -200.6% | 23.5% | ||
| Q1 24 | -317.7% | -1.4% |
资本支出强度ASMBFUSB
| Q4 25 | — | 31.1% | ||
| Q3 25 | 0.4% | 5.9% | ||
| Q2 25 | 0.0% | 21.8% | ||
| Q1 25 | 0.0% | 0.7% | ||
| Q4 24 | 0.4% | 21.6% | ||
| Q3 24 | 0.0% | 6.6% | ||
| Q2 24 | 0.2% | 2.0% | ||
| Q1 24 | 0.2% | 9.8% |
现金转化率ASMBFUSB
| Q4 25 | — | 5.79× | ||
| Q3 25 | — | 2.18× | ||
| Q2 25 | — | 25.16× | ||
| Q1 25 | — | 0.99× | ||
| Q4 24 | — | 4.53× | ||
| Q3 24 | — | 0.87× | ||
| Q2 24 | — | 1.20× | ||
| Q1 24 | — | 0.39× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
